Redcare Pharmacy NV (SHPPF)
USD 135.79
(-0.12%)
USD 135.79
(-0.12%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 161.05 Million EUR | -14.67% |
| 2022 | 188.75 Million EUR | 1873.49% |
| 2021 | -10.64 Million EUR | 79.49% |
| 2020 | -51.88 Million EUR | -159.94% |
| 2019 | 86.54 Million EUR | 34.46% |
| 2018 | 64.36 Million EUR | 1780.14% |
| 2017 | -3.83 Million EUR | 89.97% |
| 2016 | -38.2 Million EUR | -346.89% |
| 2015 | 15.47 Million EUR | 5309.76% |
| 2014 | -297 Thousand EUR | -222.83% |
| 2013 | -92 Thousand EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 133.29 Million EUR | -7.91% |
| 2024 Q1 | 144.73 Million EUR | -10.14% |
| 2023 Q2 | 126.51 Million EUR | -20.4% |
| 2023 Q3 | 92.63 Million EUR | -26.78% |
| 2023 FY | 161.05 Million EUR | -14.67% |
| 2023 Q1 | 158.93 Million EUR | -15.8% |
| 2023 Q4 | 161.05 Million EUR | 73.87% |
| 2022 Q1 | -18.68 Million EUR | -75.6% |
| 2022 Q3 | 159.48 Million EUR | 277.38% |
| 2022 FY | 188.75 Million EUR | 1873.49% |
| 2022 Q2 | 42.26 Million EUR | 326.12% |
| 2022 Q4 | 188.75 Million EUR | 18.36% |
| 2021 Q3 | -24.7 Million EUR | 29.21% |
| 2021 Q1 | -47.33 Million EUR | 8.76% |
| 2021 FY | -10.64 Million EUR | 79.49% |
| 2021 Q4 | -10.64 Million EUR | 56.92% |
| 2021 Q2 | -34.9 Million EUR | 26.27% |
| 2020 Q2 | 54.16 Million EUR | -50.68% |
| 2020 Q1 | 109.83 Million EUR | 26.91% |
| 2020 FY | -51.88 Million EUR | -159.94% |
| 2020 Q4 | -51.88 Million EUR | -196.98% |
| 2020 Q3 | 53.49 Million EUR | -1.24% |
| 2019 Q2 | -86.46 Million EUR | -220.7% |
| 2019 FY | 86.54 Million EUR | 34.46% |
| 2019 Q4 | 86.54 Million EUR | 223.25% |
| 2019 Q3 | -70.22 Million EUR | 18.79% |
| 2019 Q1 | 71.64 Million EUR | 11.3% |
| 2018 Q4 | 64.36 Million EUR | 260.09% |
| 2018 FY | 64.36 Million EUR | 1780.14% |
| 2018 Q1 | -17.99 Million EUR | -369.77% |
| 2018 Q2 | -52.82 Million EUR | -193.49% |
| 2018 Q3 | -40.2 Million EUR | 23.88% |
| 2017 Q3 | -30.46 Million EUR | -3.24% |
| 2017 FY | -3.83 Million EUR | 89.97% |
| 2017 Q4 | -3.83 Million EUR | 87.42% |
| 2017 Q1 | -34.91 Million EUR | 8.61% |
| 2017 Q2 | -29.5 Million EUR | 15.48% |
| 2016 Q1 | 3.52 Million EUR | -77.19% |
| 2016 Q2 | 9.25 Million EUR | 162.31% |
| 2016 Q4 | -38.2 Million EUR | -376.83% |
| 2016 Q3 | 13.8 Million EUR | 49.08% |
| 2016 FY | -38.2 Million EUR | -346.89% |
| 2015 Q4 | 15.47 Million EUR | 0.0% |
| 2015 FY | 15.47 Million EUR | 5309.76% |
| 2015 Q1 | 297 Thousand EUR | 0.0% |
| 2014 FY | -297 Thousand EUR | -222.83% |
| 2013 FY | -92 Thousand EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 415.78 Thousand USD | -38635.846% |
| Allstar Health Brands, Inc. | 2.21 Million USD | -7187.52% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | -111.13 Million USD | 244.928% |
| Café Serendipity Holdings, Inc. | 409.94 Thousand USD | -39188.241% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 271.74 Thousand USD | -59169.522% |
| HealthWarehouse.com, Inc. | 2.17 Million USD | -7315.383% |
| LIGAND PHARMACEUTICAL INC | -16.78 Million USD | 1059.313% |
| MedGen, Inc. | 24.36 USD | -661161640.558% |
| Omni Health, Inc. | 1.46 Million USD | -10916.656% |
| Oxford Investments Holdings Inc. | 172.66 Thousand USD | -93176.693% |
| Pineapple, Inc. | 8.1 Million USD | -1886.06% |
| ScripsAmerica, Inc. | 748.59 Thousand USD | -21414.924% |